Literature DB >> 7558335

Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection.

J B Goldberg1, M J Coyne, A N Neely, I A Holder.   

Abstract

The virulence of wild-type Pseudomonas aeruginosa PAO1 and that of a genetically defined algC mutant, PAO1 algC::tet, were compared in a burned-mouse model of infection. Unlike PAO1, PAO1 algC::tet was avirulent, grew less well in the eschar, and did not disseminate to the liver of challenged animals. We have previously shown that the P. aeruginosa algC gene is required for biosynthesis of alginate and lipopolysaccharide (M.J. Coyne, Jr., K.S. Russell, C.L. Coyle, and J.B. Goldberg, J. Bacteriol. 176:3500-3507, 1994). In order to determine whether the alginate or lipopolysaccharide (LPS) defect was responsible for the avirulence of this strain, we constructed a strain with a mutation in an alginate-specific gene, algD. PAO1-algD was virulent in the burned-mouse model, thus implicating the LPS defect in PAO1 algC::tet as the relevant alteration responsible for the avirulence of this strain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558335      PMCID: PMC173586          DOI: 10.1128/iai.63.10.4166-4169.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  A more sensitive plate assay for detection of protease production by Pseudomanas aeruginosa.

Authors:  P A Sokol; D E Ohman; B H Iglewski
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

2.  PSEUDOMONAS BURN WOUND SEPSIS. I PATHOGENESIS OF EXPERIMENTAL PSEUDOMONAS BURN WOUND SEPSIS.

Authors:  C TEPLITZ; D DAVIS; A D MASON; J A MONCRIEF
Journal:  J Surg Res       Date:  1964-05       Impact factor: 2.192

3.  Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues.

Authors:  D G Saymen; P Nathan; I A Holder; E O Hill; B G Macmillan
Journal:  Appl Microbiol       Date:  1972-03

4.  Pseudomonas aeruginosa infection in cystic fibrosis: nucleotide sequence and transcriptional regulation of the algD gene.

Authors:  V Deretic; J F Gill; A M Chakrabarty
Journal:  Nucleic Acids Res       Date:  1987-06-11       Impact factor: 16.971

5.  Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa.

Authors:  S J Cryz; T L Pitt; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa.

Authors:  G B Pier; D M Thomas
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

7.  Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase.

Authors:  D E Ohman; S J Cryz; B H Iglewski
Journal:  J Bacteriol       Date:  1980-06       Impact factor: 3.490

8.  Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.

Authors:  D E Ohman; A M Chakrabarty
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.

Authors:  W Engels; J Endert; M A Kamps; C P van Boven
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

10.  Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa.

Authors:  M A Luzar; T C Montie
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

View more
  20 in total

1.  Phenotypic selection and phase variation occur during alfalfa root colonization by Pseudomonas fluorescens F113.

Authors:  María Sánchez-Contreras; Marta Martín; Marta Villacieros; Fergal O'Gara; Ildefonso Bonilla; Rafael Rivilla
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

2.  Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (sigmaE).

Authors:  H Yu; J C Boucher; N S Hibler; V Deretic
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Pseudomonas aeruginosa Utilizes Host-Derived Itaconate to Redirect Its Metabolism to Promote Biofilm Formation.

Authors:  Sebastián A Riquelme; Kalle Liimatta; Tania Wong Fok Lung; Blanche Fields; Danielle Ahn; David Chen; Carmen Lozano; Yolanda Sáenz; Anne-Catrin Uhlemann; Barbara C Kahl; Clemente J Britto; Emily DiMango; Alice Prince
Journal:  Cell Metab       Date:  2020-05-18       Impact factor: 27.287

4.  Genetics of swarming motility in Salmonella enterica serovar typhimurium: critical role for lipopolysaccharide.

Authors:  A Toguchi; M Siano; M Burkart; R M Harshey
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

5.  Phosphoglucomutase of Yersinia pestis is required for autoaggregation and polymyxin B resistance.

Authors:  Suleyman Felek; Artur Muszyński; Russell W Carlson; Tiffany M Tsang; B Joseph Hinnebusch; Eric S Krukonis
Journal:  Infect Immun       Date:  2009-12-22       Impact factor: 3.441

6.  The transcriptional regulator AlgR is essential for Pseudomonas aeruginosa pathogenesis.

Authors:  Stephen E Lizewski; Derek S Lundberg; Michael J Schurr
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 7.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

8.  Optical monitoring and treatment of potentially lethal wound infections in vivo.

Authors:  Michael R Hamblin; Touqir Zahra; Christopher H Contag; Albert T McManus; Tayyaba Hasan
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

9.  Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance.

Authors:  Geoffrey A McKay; Donald E Woods; Kelly L MacDonald; Keith Poole
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

Review 10.  Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.

Authors:  Gerald B Pier
Journal:  Int J Med Microbiol       Date:  2007-04-27       Impact factor: 3.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.